OBJECTIVE To establish a high-risk medication list and preventive and therapeutic measures for drug-induced hypofibrinogenemia， and to provide a reference for the prevention and treatment of this condition. METHODS By integrating domestic and international case reports， retrospective case-control studies， and spontaneous adverse drug reaction reporting databases， 19 domestically marketed high-risk drugs for drug-induced hypofibrinogenemia were identified. Based on the clinical characteristics and mechanisms of these drugs， relevant risk factors were systematically reviewed， and existing treatment options were summarized， leading to the preliminary development of recommended preventive and therapeutic measures. A two-round Delphi consultation was conducted to evaluate， revise， and ultimately reach consensus on the preliminary findings， using a mean importance score of ≥3.5 points for indicators and a coefficient of variation ＜0.3 as screening criteria. RESULTS The coefficient of expert authority for both rounds of expert consultation was 0.904. In the first round， the Kendall coordination coefficients （Kendall’s W ） for the high-risk medication list and the proposed preventive and therapeutic measures were 0.390 and 0.223 （ P ＜0.05）， respectively. In the second round， the Kendall’s W were 0.227 and 0.200 （ P ＜0.05）， respectively. After two rounds of expert consultation and discussion， 11 high-risk drugs for drug-induced hypofibrinogenemia， represented by hemocoagulase and certain anti-infective agents， were ultimately identified， along with 5 preventive and therapeutic measures spanning the entire process of “pre-medication assessment， intra-medication monitoring， and bleeding event management”. CONCLUSIONS This study has established a scientific and reliable high-risk medication list， and corresponding preventive and therapeutic measures for drug-induced hypofibrinogenemia， providing a theoretical basis and practical support for the early identification， stratified management， and precise intervention of this condition.

Objectives:To investigate the relationship between serum miR-550a-5p levels and spinal metas-tasis in patients with non-small cell lung cancer(NSCLC).Methods:The clinical data of 175 patients with NSCLC who received treatment in the Affiliated Hospital of Chengde Medical College between May 2021 and May 2023 were retrospectively analyzed.According to the results of whole body bone imaging,70 patients with spinal metastasis were enrolled into the metastasis group,and 104 patients without spinal metastasis were enrolled into the none-metastasis group.There were no statistically significant differences in gender,age,smoking,hypertension,thrombosis,and tumor location between the two groups(P＞0.05).The pathological type,clinical stage,lymph node metastasis,and tumor diameter of the patients were collected and compared between the two groups.qRT-PCR was used to detect the expression level of serum miR-550a-5p,enzyme-linked immunosorbent assay was used to detect the serum tartrate-resistant acid phosphatase-5b(TRACP-5b)and type Ⅰ collagen cross-linked C-terminal peptide(ICTP)levels.The differences in serum levels of TRACP-5b,ICTP,and miR-550a-5p were compared between the two groups.The receiver operating characteristic(ROC)curve was adopted to evaluate the diagnostic value of miR-550a-5p,TRACP-5b,and ICTP alone and in combination for spinal metastasis in NSCLC patients.Results:Compared with the none-metastasis group,serum TRACP-5b,ICTP,and miR-550a-5p levels were significantly higher in patients in the metastasis group(P＜0.05).The miR-550a-5p level was significantly higher in patients with tumor diameter≥5cm,lung adenocarcinoma,stage Ⅲ-Ⅳ,and lymph node metastasis than in patients with tumor diameter＜5cm,squamous carcinoma,stage Ⅰ-Ⅱ,and no lymph node metastasis(P＜0.05).Elevated serum miR-550a-5p,lung adenocarcinoma,stage Ⅲ-Ⅳ,and lymph node metastasis were the independent risk factors for the development of spinal metastasis in NSCLC patients(P＜0.05).The AUC of miR-550a-5p for diagnosing spinal metastasis in NSCLC patients was 0.851,and the sensitivity and specificity were 74.29％and 85.58％,respectively,at the optimal cut-off value of 0.20.The diagnostic efficacy of serum miR-550a-5p for diagnosing spinal metastasis in NSCLC patients was significantly better than that of TRACP-5b(Z=2.309,P=0.023)and ICTP(Z=1.852,P=0.049).The AUC of miR-550a-5p,TRACP-5b,and ICTP combination for the diagnosis of spinal metastasis in NSCLC patients was 0.931,and the sensitivity and specificity were 88.57％and 87.50％,respectively.The diagnostic efficacy of the three-marker combination was significantly better than that of the two-marker combination of TRACP-5b and ICTP(Z=2.205,P=0.027).Conclusions:Elevated level of serum miR-550a-5p is associated with spinal metastasis,which can be used as a molecular marker for predicting spinal metastasis in NSCLC patients,moreover,its combination use with bone metabolism-related tumor markers,the ICTP and TRACP-5b,can improve diagnostic efficacy.

Objective:Based on the adverse drug event active surveillance and assessment system-Ⅱ (ADE-ASAS-Ⅱ) and the information of inpatients in the hospital information system (HIS), the automatic monitoring module of movement disorders was constructed and its application effect in the real-world study of drug-induced movement disorders (DIMDs) was explored.Methods:Literature reviews, case reports, spontaneous reports and medical records were collected, the keyword set was screened based on ADE-ASAS-Ⅱ system and text classification technology, and an automatic monitoring module was constructed. The information of hospitalized patients in Chinese PLA General Hospital (our hospital) was selected from October 10 to 16, 2022. The results of manual evaluation and the system alarm by the automatic monitoring module were compared, and the performance of the automatic monitoring module was evaluated and optimized through repeated machine learning. The medical record information of hospitalized patients who used sodium valproate throughout the year in our hospital in 2022 were collected, and the occurrence of movement disorders related to sodium valproate was analyzed using the automatic monitoring module.Results:A total of 4 918 hospitalized patients (146 with movement disorders) were collected, and the final setting conditions of the automatic monitoring module were determined, including inclusion criteria (43 text keywords, 3 diagnosis) and exclusion criteria (11 text and 20 document titles were omitted). Among the 1 138 hospitalized patients using sodium valproate in 2022, the incidence of DIMDs with tic and tremor as main clinical manifestations detected by automatic monitoring module was 1.67% (19/1 138).Conclusion:The automatic monitoring module of drug-induced movement disorders based on machine learning and manual evaluation can be applied to explore the occurrence characteristics of DIMDs in the real world, and provide information for pharmacovigilance in clinic.

OBJECTIVE To statistically analyze and detect signals for the adverse drug reactions(ADRs)related to tigecycline based on the ADR spontaneous reporting system,so as to provide reference for the prevention of medi-cation risks of tigecycline.METHODS ADR reports of tigecycline were extracted from the ADR spontaneous repor-ting system of the hospital from Oct.2013 to Mar.2024.Statistical analysis was conducted by Microsoft Excel and Free Statistics 2.1.1.The data mining and analysis were performed using the reporting odds ratio(ROR),the proportional reporting ratio(PRR)and the composite criteria of UK Medicines and Healthcare products Regulato-ry Agency(MHRA).RESULTS Among the 574 ADR reports with tigecycline as the primarily suspected drug,elderly patients accounted for over 50％.The ADRs mainly occurred within one week after medication administra-tion,involving 12 organ systems and 57 adverse reaction signals.Through comprehensive analysis using three methods,20 positive risk signals related to tigecycline were identified,mainly affecting the gastrointestinal system,hepatobiliary system and hematological system.The top 5 frequent ADR signals were nausea,vomiting,diarrhea,thrombocytopenia and hyperbilirubinemia.According to the ROR method,the top five ranked ADR sig-nals were hyperbilirubinemia(ROR=330.55),hepatocellular injury(ROR=110.22),elevated amylase(ROR=78.90),cholestasis(ROR=73.32),and decreased fibrinogen(ROR=43.65).CONCLUSIONS The adverse reac-tions of tigecycline mainly occur during the initial stage of medication,and special caution is required when used in elderly patients.High-intensity risk signals for ADRs are hyperbilirubinemia,liver injury,and others related to hematological system and gastrointestinal system.Close monitoring of these ADRs and timely intervention are necessary during medication.

OBJECTIVES: To evaluate the application value of genetic newborn screening (gNBS) in the Yunnan region. METHODS: A prospective study was conducted with a random selection of 3 001 newborns born in the Yunnan region from February to December 2021. Traditional newborn screening (tNBS) was used to test biochemical indicators, and targeted next-generation sequencing was employed to screen 159 genes related to 156 diseases. Positive-screened newborns underwent validation and confirmation tests, and confirmed cases received standardized treatment and long-term follow-up. RESULTS: Among the 3 001 newborns, 166 (5.53%) were initially positive for genetic screening, and 1 435 (47.82%) were genetic carriers. The top ten genes with the highest variation frequency were GJB2 (21.29%), DUOX2 (7.27%), HBA (6.14%), GALC (3.63%), SLC12A3 (3.33%), HBB (3.03%), G6PD (2.94%), SLC25A13 (2.90%), PAH (2.73%), and UNC13D (2.68%). Among the initially positive newborns from tNBS and gNBS, 33 (1.10%) and 47 (1.57%) cases were confirmed, respectively. A total of 48 (1.60%) cases were confirmed using gNBS+tNBS. The receiver operating characteristic curve analysis demonstrated that the areas under the curve for tNBS, gNBS, and gNBS+tNBS in diagnosing diseases were 0.866, 0.982, and 0.968, respectively (P<0.05). DeLong's test showed that the area under the curve for gNBS and gNBS+tNBS was higher than that for tNBS (P<0.05). CONCLUSIONS gNBS can expand the range of disease detection, and its combined use with tNBS can significantly shorten diagnosis time, enabling early intervention and treatment.
Humans ; Infant, Newborn ; Neonatal Screening ; Genetic Testing ; Female ; Male ; Follow-Up Studies ; Prospective Studies ; China

Objectives:To investigate the relationship between serum miR-550a-5p levels and spinal metas-tasis in patients with non-small cell lung cancer(NSCLC).Methods:The clinical data of 175 patients with NSCLC who received treatment in the Affiliated Hospital of Chengde Medical College between May 2021 and May 2023 were retrospectively analyzed.According to the results of whole body bone imaging,70 patients with spinal metastasis were enrolled into the metastasis group,and 104 patients without spinal metastasis were enrolled into the none-metastasis group.There were no statistically significant differences in gender,age,smoking,hypertension,thrombosis,and tumor location between the two groups(P＞0.05).The pathological type,clinical stage,lymph node metastasis,and tumor diameter of the patients were collected and compared between the two groups.qRT-PCR was used to detect the expression level of serum miR-550a-5p,enzyme-linked immunosorbent assay was used to detect the serum tartrate-resistant acid phosphatase-5b(TRACP-5b)and type Ⅰ collagen cross-linked C-terminal peptide(ICTP)levels.The differences in serum levels of TRACP-5b,ICTP,and miR-550a-5p were compared between the two groups.The receiver operating characteristic(ROC)curve was adopted to evaluate the diagnostic value of miR-550a-5p,TRACP-5b,and ICTP alone and in combination for spinal metastasis in NSCLC patients.Results:Compared with the none-metastasis group,serum TRACP-5b,ICTP,and miR-550a-5p levels were significantly higher in patients in the metastasis group(P＜0.05).The miR-550a-5p level was significantly higher in patients with tumor diameter≥5cm,lung adenocarcinoma,stage Ⅲ-Ⅳ,and lymph node metastasis than in patients with tumor diameter＜5cm,squamous carcinoma,stage Ⅰ-Ⅱ,and no lymph node metastasis(P＜0.05).Elevated serum miR-550a-5p,lung adenocarcinoma,stage Ⅲ-Ⅳ,and lymph node metastasis were the independent risk factors for the development of spinal metastasis in NSCLC patients(P＜0.05).The AUC of miR-550a-5p for diagnosing spinal metastasis in NSCLC patients was 0.851,and the sensitivity and specificity were 74.29％and 85.58％,respectively,at the optimal cut-off value of 0.20.The diagnostic efficacy of serum miR-550a-5p for diagnosing spinal metastasis in NSCLC patients was significantly better than that of TRACP-5b(Z=2.309,P=0.023)and ICTP(Z=1.852,P=0.049).The AUC of miR-550a-5p,TRACP-5b,and ICTP combination for the diagnosis of spinal metastasis in NSCLC patients was 0.931,and the sensitivity and specificity were 88.57％and 87.50％,respectively.The diagnostic efficacy of the three-marker combination was significantly better than that of the two-marker combination of TRACP-5b and ICTP(Z=2.205,P=0.027).Conclusions:Elevated level of serum miR-550a-5p is associated with spinal metastasis,which can be used as a molecular marker for predicting spinal metastasis in NSCLC patients,moreover,its combination use with bone metabolism-related tumor markers,the ICTP and TRACP-5b,can improve diagnostic efficacy.

Objective:Based on the adverse drug event active surveillance and assessment system-Ⅱ (ADE-ASAS-Ⅱ) and the information of inpatients in the hospital information system (HIS), the automatic monitoring module of movement disorders was constructed and its application effect in the real-world study of drug-induced movement disorders (DIMDs) was explored.Methods:Literature reviews, case reports, spontaneous reports and medical records were collected, the keyword set was screened based on ADE-ASAS-Ⅱ system and text classification technology, and an automatic monitoring module was constructed. The information of hospitalized patients in Chinese PLA General Hospital (our hospital) was selected from October 10 to 16, 2022. The results of manual evaluation and the system alarm by the automatic monitoring module were compared, and the performance of the automatic monitoring module was evaluated and optimized through repeated machine learning. The medical record information of hospitalized patients who used sodium valproate throughout the year in our hospital in 2022 were collected, and the occurrence of movement disorders related to sodium valproate was analyzed using the automatic monitoring module.Results:A total of 4 918 hospitalized patients (146 with movement disorders) were collected, and the final setting conditions of the automatic monitoring module were determined, including inclusion criteria (43 text keywords, 3 diagnosis) and exclusion criteria (11 text and 20 document titles were omitted). Among the 1 138 hospitalized patients using sodium valproate in 2022, the incidence of DIMDs with tic and tremor as main clinical manifestations detected by automatic monitoring module was 1.67% (19/1 138).Conclusion:The automatic monitoring module of drug-induced movement disorders based on machine learning and manual evaluation can be applied to explore the occurrence characteristics of DIMDs in the real world, and provide information for pharmacovigilance in clinic.

OBJECTIVE To statistically analyze and detect signals for the adverse drug reactions(ADRs)related to tigecycline based on the ADR spontaneous reporting system,so as to provide reference for the prevention of medi-cation risks of tigecycline.METHODS ADR reports of tigecycline were extracted from the ADR spontaneous repor-ting system of the hospital from Oct.2013 to Mar.2024.Statistical analysis was conducted by Microsoft Excel and Free Statistics 2.1.1.The data mining and analysis were performed using the reporting odds ratio(ROR),the proportional reporting ratio(PRR)and the composite criteria of UK Medicines and Healthcare products Regulato-ry Agency(MHRA).RESULTS Among the 574 ADR reports with tigecycline as the primarily suspected drug,elderly patients accounted for over 50％.The ADRs mainly occurred within one week after medication administra-tion,involving 12 organ systems and 57 adverse reaction signals.Through comprehensive analysis using three methods,20 positive risk signals related to tigecycline were identified,mainly affecting the gastrointestinal system,hepatobiliary system and hematological system.The top 5 frequent ADR signals were nausea,vomiting,diarrhea,thrombocytopenia and hyperbilirubinemia.According to the ROR method,the top five ranked ADR sig-nals were hyperbilirubinemia(ROR=330.55),hepatocellular injury(ROR=110.22),elevated amylase(ROR=78.90),cholestasis(ROR=73.32),and decreased fibrinogen(ROR=43.65).CONCLUSIONS The adverse reac-tions of tigecycline mainly occur during the initial stage of medication,and special caution is required when used in elderly patients.High-intensity risk signals for ADRs are hyperbilirubinemia,liver injury,and others related to hematological system and gastrointestinal system.Close monitoring of these ADRs and timely intervention are necessary during medication.

OBJECTIVE To explore clinical characteristics and risk factors of drug-induced hypofibrinogenemia,providing a reference for rational clinical drug use.METHODS Retrospective case analyses literature on drug-induced hypofibrinogenemia were collected from domestic and international databases from their inception to December 31,2024.The patients'gender,age,fibrinogen(FIB)levels before and after treatment,drug types,the incidence of drug-induced hypofibrinogenemia,time of occurrence,bleeding rates,clinical manifestations,risk factors,and protective factors were all analyzed.RESULTS A total of 40 retrospective case analysis studies were included,involving 17 313 patients.Patient age ranged from 0.83 to 78.40 years,with males accounting for 16.90%-81.00%.The involved drugs comprised 5 categories and 13 specific agents,including tigecycline,snake venom hemocoagulase,tocilizumab,and alteplase,etc.The incidence of drug-induced hypofibrinogenemia ranged from 0 to 100%,occurring between 2 hours and 9 months after drug administration,and FIB levels rebounded in most patients after drug discontinuation.The bleeding rate varied from 0%to 91.30%,including epistaxis,airway bleeding,gastrointestinal bleeding,and cerebral hemorrhage.Risk factors included high drug dosage,prolonged treatment duration,abdominal infection,advanced age,and low baseline FIB levels.Protective factors were only mentioned in studies on tigecycline,including skin and soft tissue infections and high baseline FIB levels.CONCLUSIONS Drug-induced hypofibrinogenemia is commonly associated with tigecycline,hemocoagulase,and tocilizumab.Its clinical features vary depending on the drug,and risk factors include high drug dosage,prolonged treatment,low baseline FIB levels,and advanced age.For high-risk medications,individualized medication management and monitoring of FIB levels are recommended.

As a novel iron-dependent form of cell death, ferroptosis is characterized by the excessive accumulation of phospholipids containing polyunsaturated fatty acids (PUFA) on the cell membrane and peroxidation. Lipid droplets are always in the dynamic transition of generation and decomposition, play a central role in regulating lipid metabolism, and are always in the dynamic transition of generation and decomposition. Lipid droplet metabolism is closely related to the occurrence of ferroptosis and plays an important role in the disease caused by ferroptosis. This review firstly focuses on the lipid droplet metabolism process and its effects on the storage and release of PUFA, and further elucidates the regulatory mechanism and key regulatory proteins of lipid drop metabolism on ferroptosis, in order to reveal the intrinsic relationship between lipid droplets and ferroptosis, and provide a new strategy for disease prevention and treatment.